Literature DB >> 34259774

The role of serum inflammatory markers, albumin, and hemoglobin in predicting the diagnosis in patients admitted to the emergency department with a pre-diagnosis of COVID-19.

Canan Akman1, Serkan Bakırdöğen2.   

Abstract

OBJECTIVE: Serum inflammatory markers and albumin levels provide an assumption for the severity of COVID-19 infection. Our objective was to investigate the determinant role of serum inflammatory markers, albumin, and hemoglobin (Hb) in predicting the diagnosis in patients with a pre-diagnosis of COVID-19.
METHODS: Demographic findings, complete blood count and serum biochemical values of the patients analyzed.
RESULTS: Of the patients included in the study, 48 were COVID (+) and 253 were COVID (-). Statistically significant difference was found in terms of hemoglobin, mean platelet volume, and monocyte/eosinophil ratio.
CONCLUSIONS: The levels of serum albumin, hemoglobin, monocyte/eosinophil ratio, and mean platelet volume can be predictive factors for diagnosis in patients with COVID-19.

Entities:  

Year:  2021        PMID: 34259774     DOI: 10.1590/1806-9282.67.Suppl1.20200917

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  1 in total

1.  Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain.

Authors:  Jordi Mayneris-Perxachs; Maria Francesca Russo; Rafel Ramos; Ana de Hollanda; Arola Armengou Arxé; Matteo Rottoli; María Arnoriaga-Rodríguez; Marc Comas-Cufí; Michele Bartoletti; Ornella Verrastro; Carlota Gudiol; Ester Fages; Marga Giménez; Ariadna de Genover Gil; Paolo Bernante; Francisco Tinahones; Jordi Carratalà; Uberto Pagotto; Ildefonso Hernández-Aguado; Fernando Fernández-Aranda; Fernanda Meira; Antoni Castro Guardiola; Geltrude Mingrone; José Manuel Fernández-Real
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-02       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.